Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma
A 79-year-old Japanese man underwent a medical examination for hoarseness. Computed tomography revealed a left renal tumor, and radical nephrectomy was performed. The tumor was a clear cell carcinoma. Fourteen months after the operation, the tumor had metastasized to the spleen, right lung, and retr...
Saved in:
| Main Authors: | Ryo Kasahara, Noboru Nakaigawa, Kazuki Kobayashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2017/2648471 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma
by: Isabella Portugal, et al.
Published: (2024-11-01) -
Development of Nephrotic Syndrome after Administration of Sorafenib in a Case of Metastatic Renal Cell Carcinoma
by: Yumiko Okuno, et al.
Published: (2011-01-01) -
Response to Ipilimumab/Nivolumab Rechallenge and BRAF Inhibitor/MEK Inhibitor Rechallenge in a Patient with Advanced Metastatic Melanoma Previously Treated with BRAF Targeted Therapy and Immunotherapy
by: Caitlyn N. Myrdal, et al.
Published: (2020-01-01) -
Efficacy and Safety of Second‐Line Immune Checkpoint Inhibitor Rechallenge in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study
by: Wensi Zhao, et al.
Published: (2025-07-01) -
Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge
by: Taro Ikeda, et al.
Published: (2021-01-01)